• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Pancreatic Cancer
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Pancreatic Cancer trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Pancreatic Cancer research

Pancreatic cancer often goes undetected until it has reached an advanced stage, at which point it becomes difficult to treat. Researchers are working to develop new and effective therapies for better prognoses, but they need the right tools. Signant SmartSignals solutions can generate reliable evidence while offering a patient-centric experience.

Pancreatic Cancer

Why Signant Health

  • Capture Accurate PRO Data
  • Simplify Consent & Reconsent
  • Gain Richer Insights
  • Reduce On-Site Visits
  • Optimize Supply Management
  • Capture Accurate PRO Data

    Capture Accurate PRO Data

    Signant’s pre-configured eCOA solution features a library of validated, disease-specific instruments to accelerate study startup times. Capture real-time insights into the patients’ symptoms, satisfaction with the treatment, as well as the treatment’s effect on their quality of life. It's 33% faster than other eCOA options and will reduce your costs by 20%.
     

  • Simplify Consent & Reconsent

    Simplify Consent & Reconsent

    Choose any of our tiered eConsent solutions to help convey complex information about the study and disease to patients. The solution lets patients flag sections they need clarified and checks their comprehension for a truly informed consent. It manages protocol amendments and the reconsent process, so that the correct forms are always completed.
     

  • Gain Richer Insights

    Gain Richer Insights

    Help your study team collect accurate data about treatment effects on patient function. We integrate ActiGraph with our eCOA system to automatically collect sleep and activity data without additional burden on patients or sites. Study teams can view this data alongside COA data for a more complete evaluation of patient function.
     
     

  • Reduce On-Site Visits

    Reduce On-Site Visits

    Our secure and compliant Telemedicine solution replaces on-site visits with convenient video consultations, making it possible to reach a wider, more diverse patient population. The virtual platform allows study teams to frequently check in and communicate with patients.
     
     

  • Optimize Supply Management

    Optimize Supply Management

    Randomization & Trial Supply Management (RTSM) handles multiple patient cohorts and adaptive dosing schedules involved in pancreatic cancer research with ease. We also utilize unique algorithms minimize waste as well as an agile-based design approach that helps study teams launch quickly.
     
     
     

Comprehensive Pancreatic Cancer experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Pancreatic Cancer trial resources
SOLUTION BROCHURE

Pancreatic Cancer Trial Solutions Overview


GET INSIGHTS
VIDEO

Pancreatic Cancer Trial Solutions


WATCH [2 MIN]
SOLUTIONS

Oncology Clinical Trial Solutions

 
LEARN MORE

eClinical solutions for Pancreatic Cancer trials

Ready to learn more?

Discover how Signant can support your current or upcoming pancreatic cancer trials. 

DOWNLOAD BROCHURE GET STARTED